Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Small Value Momentum in Different Packages

BY | ETF Database
02/24/2025 | 242 VIEWS
The ETF flow leader board tends to show many large funds getting even larger. However, when I looked last week, one more moderately sized ETF caught my eye.The VictoryShares US Small Mid Cap Value Momentum ETF (USVM B+) gathered $615 million of net inflows year-to-date through February 20. Despite launching in October 2017, the fund had been off the radar for many investors for years. However, now the fund has over $900 million in assets. The fund’s tripling in size in such a short period of time is impressive. What’s Inside the VictoryShares ETFUSVM might be the most descriptive ETF trading today. It focuses on small- and mid-cap U.S. stocks. That have attractive value characteristics and that also have favorable price momentum traits.  Approximately 290 companies make it into USVM. Relative to the Nasdaq US Small Mid Cap 1300 Index, USVM has significantly lower P/E and P/B ratios but only slightly lower historical earnings growth. Health care (16% of assets), industrials (16%), financials (14%), and consumer discretionary (14%) stocks are well represented in the diversified ETF. Merit Medical Systems, Old Republic International and Rithm Capital are some of the fund’s largest holdings. The ETF gathered most of its net inflows this year over a three-day period in mid January. However, USVM has seen modest daily inflows in the subsequent month. The fund takes a different multi-factor approach than its cousin, the VictoryShares Small Cap Free Cash Flow ETF (SFLO ). SFLO combines quality and small size factors to build a forward-looking free cash flow ETF.A Peer that Looks Very DifferentUSVM is not the only ETF seeking out smaller, undervalued companies with strong price momentum. The  Invesco S&P SmallCap Value with Momentum ETF (XSVM B) is a peer. XSVM will turn 10 years old in a few weeks. The ETF had approximately $730 million in assets. Despite a similar name to USVM, XSVM is built differently.  XSVM has a whopping 46% of assets in financial stocks. The XSVM stake is triple that of its small-cap value momentum peer and double that of the S&P 600 Small Cap index. Consumer discretionary (17%) and industrials (14%) stocks were also widely held by the Invesco ETF.   Meanwhile, health care stocks represented only 2% of XSVM. This is also notably different from the VictoryShares fund. Asbury Automotive Group, Lincoln National, and StoneX Group are a few of the larger positions.Holdings Matter More than FeesIn the past 12 months, USVM rose 18%, significantly outperforming XSVM’s 4.2% gain. The performance spread between the two funds showcases the distinctions between the two portfolios. Of course, past performance is not indicative of future results. While many people choose an ETF based on the expense ratio, we think this is less appropriate for multi-factor ETFs. The USVM fee is 0.30%, only seven basis points less than XSVM. Unlike USVM, XSVM has seen modest net outflows in 2025. If making America even stronger stays in focus, then ETFs owning small cap companies stand to benefit. They have less multinational exposure.For more news, information, and analysis, visit VettaFI | ETFDB.

More Commentary

Top Performing Leveraged/Inverse ETFs: 03/30/2025
BY | ETF Database
04/02/2025 | 6 VIEWS
Top Active ETF TCAF Adds More Than Half a Billion in 1 Month
BY | ETF Database
04/02/2025 | 43 VIEWS
Sell on the Pop Prospects: April 2 Edition
BY | ETF Database
04/02/2025 | 5 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.